Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine

Alvin V Terry, R. Williamson, M. Gattu, J. W. Beach, C. R. McCurdy, J. A. Sparks, J. R. Pauly

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

In the present study, lobeline and two structurally simplified analogs were evaluated for activity in muscarinic and nicotinic binding assays, a functional assay for nicotinic receptor activation (86Rb+ efflux from striatal synaptosomes) and an acetylcholinesterase (ACHE) assay. Lobeline displaced [3H]cytisine binding to rat cortical membranes with a mean inhibition constant (K1) value of 16.0 nM, while the lobeline analogs CRM- I-13-1 and CRM-I-32-1 exhibited values of 15.0 and 5.4 μM, respectively. [3H]methylscopolamine was displaced by lobeline with a mean K(I) value of 37.0 μM while CRM-I-13-1 and CRM-I-32-1 exhibited values of 55.0 and 16.0 μM, respectively. While nicotine stimulated 86Rb+ efflux from striatal synaptosomes in a mecamylamine reversible manner at each concentration tested, lobeline slightly increased 86Rb+ efflux at lower concentrations and reduced efflux at higher concentrations. Further, none of the lobeline effects were reversed with mecamylamine. Although less potent, the two lobeline analogs exhibited a similar pattern of activity. These data may suggest that lobeline and structurally similar compounds bind with different subtype selectivity than nicotine, or exert their agonists effects through non-nicotinic mechanisms. All of the compounds tested were at least several hundred times less potent than physostigmine as AChE inhibitors. While some differences were apparent between the lobeline analog which contained the 2- keto-ethyl portion of lobeline and the analog which contained the phenyl 2- hydroxy-ethyl moiety, each compound was much less active than lobeline in most parameters assessed.

Original languageEnglish (US)
Pages (from-to)93-102
Number of pages10
JournalNeuropharmacology
Volume37
Issue number1
DOIs
StatePublished - Jan 1 1998

Fingerprint

Lobeline
Nicotine
Mecamylamine
Corpus Striatum
Synaptosomes
Physostigmine
Nicotinic Receptors
Acetylcholinesterase
Cholinergic Agents

Keywords

  • Acetycholine
  • Cholinergicy
  • Lobeline
  • Nicotine
  • Receptors

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine. / Terry, Alvin V; Williamson, R.; Gattu, M.; Beach, J. W.; McCurdy, C. R.; Sparks, J. A.; Pauly, J. R.

In: Neuropharmacology, Vol. 37, No. 1, 01.01.1998, p. 93-102.

Research output: Contribution to journalArticle

Terry, Alvin V ; Williamson, R. ; Gattu, M. ; Beach, J. W. ; McCurdy, C. R. ; Sparks, J. A. ; Pauly, J. R. / Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine. In: Neuropharmacology. 1998 ; Vol. 37, No. 1. pp. 93-102.
@article{2c0a7e84a1c3445984740ddeedd9306f,
title = "Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine",
abstract = "In the present study, lobeline and two structurally simplified analogs were evaluated for activity in muscarinic and nicotinic binding assays, a functional assay for nicotinic receptor activation (86Rb+ efflux from striatal synaptosomes) and an acetylcholinesterase (ACHE) assay. Lobeline displaced [3H]cytisine binding to rat cortical membranes with a mean inhibition constant (K1) value of 16.0 nM, while the lobeline analogs CRM- I-13-1 and CRM-I-32-1 exhibited values of 15.0 and 5.4 μM, respectively. [3H]methylscopolamine was displaced by lobeline with a mean K(I) value of 37.0 μM while CRM-I-13-1 and CRM-I-32-1 exhibited values of 55.0 and 16.0 μM, respectively. While nicotine stimulated 86Rb+ efflux from striatal synaptosomes in a mecamylamine reversible manner at each concentration tested, lobeline slightly increased 86Rb+ efflux at lower concentrations and reduced efflux at higher concentrations. Further, none of the lobeline effects were reversed with mecamylamine. Although less potent, the two lobeline analogs exhibited a similar pattern of activity. These data may suggest that lobeline and structurally similar compounds bind with different subtype selectivity than nicotine, or exert their agonists effects through non-nicotinic mechanisms. All of the compounds tested were at least several hundred times less potent than physostigmine as AChE inhibitors. While some differences were apparent between the lobeline analog which contained the 2- keto-ethyl portion of lobeline and the analog which contained the phenyl 2- hydroxy-ethyl moiety, each compound was much less active than lobeline in most parameters assessed.",
keywords = "Acetycholine, Cholinergicy, Lobeline, Nicotine, Receptors",
author = "Terry, {Alvin V} and R. Williamson and M. Gattu and Beach, {J. W.} and McCurdy, {C. R.} and Sparks, {J. A.} and Pauly, {J. R.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0028-3908(97)00142-1",
language = "English (US)",
volume = "37",
pages = "93--102",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine

AU - Terry, Alvin V

AU - Williamson, R.

AU - Gattu, M.

AU - Beach, J. W.

AU - McCurdy, C. R.

AU - Sparks, J. A.

AU - Pauly, J. R.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - In the present study, lobeline and two structurally simplified analogs were evaluated for activity in muscarinic and nicotinic binding assays, a functional assay for nicotinic receptor activation (86Rb+ efflux from striatal synaptosomes) and an acetylcholinesterase (ACHE) assay. Lobeline displaced [3H]cytisine binding to rat cortical membranes with a mean inhibition constant (K1) value of 16.0 nM, while the lobeline analogs CRM- I-13-1 and CRM-I-32-1 exhibited values of 15.0 and 5.4 μM, respectively. [3H]methylscopolamine was displaced by lobeline with a mean K(I) value of 37.0 μM while CRM-I-13-1 and CRM-I-32-1 exhibited values of 55.0 and 16.0 μM, respectively. While nicotine stimulated 86Rb+ efflux from striatal synaptosomes in a mecamylamine reversible manner at each concentration tested, lobeline slightly increased 86Rb+ efflux at lower concentrations and reduced efflux at higher concentrations. Further, none of the lobeline effects were reversed with mecamylamine. Although less potent, the two lobeline analogs exhibited a similar pattern of activity. These data may suggest that lobeline and structurally similar compounds bind with different subtype selectivity than nicotine, or exert their agonists effects through non-nicotinic mechanisms. All of the compounds tested were at least several hundred times less potent than physostigmine as AChE inhibitors. While some differences were apparent between the lobeline analog which contained the 2- keto-ethyl portion of lobeline and the analog which contained the phenyl 2- hydroxy-ethyl moiety, each compound was much less active than lobeline in most parameters assessed.

AB - In the present study, lobeline and two structurally simplified analogs were evaluated for activity in muscarinic and nicotinic binding assays, a functional assay for nicotinic receptor activation (86Rb+ efflux from striatal synaptosomes) and an acetylcholinesterase (ACHE) assay. Lobeline displaced [3H]cytisine binding to rat cortical membranes with a mean inhibition constant (K1) value of 16.0 nM, while the lobeline analogs CRM- I-13-1 and CRM-I-32-1 exhibited values of 15.0 and 5.4 μM, respectively. [3H]methylscopolamine was displaced by lobeline with a mean K(I) value of 37.0 μM while CRM-I-13-1 and CRM-I-32-1 exhibited values of 55.0 and 16.0 μM, respectively. While nicotine stimulated 86Rb+ efflux from striatal synaptosomes in a mecamylamine reversible manner at each concentration tested, lobeline slightly increased 86Rb+ efflux at lower concentrations and reduced efflux at higher concentrations. Further, none of the lobeline effects were reversed with mecamylamine. Although less potent, the two lobeline analogs exhibited a similar pattern of activity. These data may suggest that lobeline and structurally similar compounds bind with different subtype selectivity than nicotine, or exert their agonists effects through non-nicotinic mechanisms. All of the compounds tested were at least several hundred times less potent than physostigmine as AChE inhibitors. While some differences were apparent between the lobeline analog which contained the 2- keto-ethyl portion of lobeline and the analog which contained the phenyl 2- hydroxy-ethyl moiety, each compound was much less active than lobeline in most parameters assessed.

KW - Acetycholine

KW - Cholinergicy

KW - Lobeline

KW - Nicotine

KW - Receptors

UR - http://www.scopus.com/inward/record.url?scp=0031808433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031808433&partnerID=8YFLogxK

U2 - 10.1016/S0028-3908(97)00142-1

DO - 10.1016/S0028-3908(97)00142-1

M3 - Article

VL - 37

SP - 93

EP - 102

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 1

ER -